サルモネラ菌検査・治療の世界市場：2023-2030年

世界のサルモネラ菌検査・治療市場は、予測期間中（2023～2030年）にCAGR 7.5％で成長すると予測されています。サルモネラ菌は腸管を侵す細菌性疾患です。サルモネラ菌は通常、動物やヒトの腸内に生息し、便を通じて排出されます。ヒトは汚染された水や食物を介して感染することが最も多いです。食品感染に苦しむ患者の増加が、市場の成長を支える主な要因です。Department of Agriculture, Environment and Rural Affairs（農業環境農村問題省）によると、サルモネラ菌は2,500以上の株（血清型）が知られていますが、そのほとんどが病気を引き起こすことはありません。

さらに、サルモネラ・エンテリティディスやサルモネラ・チフスムリウムのような特定の菌株は、ヒトの病気を引き起こす可能性があります。したがって、サルモネラ感染予防に対する人々の意識の高まりや政府の取り組みも、サルモネラ菌検査・治療市場を世界的に牽引する要因となっています。例えば、2003年12月には、サルモネラ菌およびその他の人獣共通感染症病原体を生産、加工、流通のすべての関連段階で検出・制御するための適切かつ効果的な対策を講じ、その蔓延と公衆衛生に及ぼすリスクを低減することを確実にするため、サルモネラ菌の制御に関する議会および理事会規則が制定されました。

セグメント別の展望

世界のサルモネラ菌検査・治療市場では、分子ベース法がかなりのシェアを占めると予測されます。

業界別では、分子ベース法のサブセグメントが世界のサルモネラ菌検査・治療市場でかなりのシェアを占めると予想されます。このセグメントの成長は、ポリメラーゼ連鎖反応（PCR）、DNA、ループ媒介等温増幅法（LAMP）、核酸配列ベース増幅法（NASBA）、組換えポリメラーゼ増幅法（RPA）、全ゲノム配列決定などの検査法の採用に起因しています。例えば、2012年3月、アボット社はジェネティクス・ラボラトリー社（GenLab）と、整形外科感染症の原因となる微生物を迅速に検出する分子診断検査の開発で提携しました。この契約に基づき、アボット社はGenLab社と共同で、PLEX-ID（TM）自動微生物同定システムで使用する新しいアッセイ法を開発し、商品化します。

地域別展望

世界のサルモネラ菌検査・治療市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されます。このうち、欧州は世界全体で突出した市場シェアを占めると予想されます。欧州連合（EU）は、鶏肉や卵など様々な食品カテゴリーにおけるサルモネラ菌検査に特定の規制を設けており、また食品の安全性に重点を置き、食品の品質を確保するために厳格な規制を実施しています。

世界のサルモネラ菌検査・治療市場において北米地域が大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の成長は、北米における食品媒介性疾患の高い流行に起因しています。米国疾病予防管理センター（CDC）によると、米国ではサルモネラ菌が140万人の感染、26,500人の入院、420人の死亡の原因になっていると推定されています。2011年のInteragency Food Safety Analytics Collaboration（IFSAC）の創設により、CDC、米国食品医薬品局（FDA）、および米国農務省食品安全検査局（USDA-FSIS）は、食中毒の発生源の推定に使用するデータと方法を改善し、4つの優先的食中毒病原体の食品発生源をタイムリーに推定することに合意した：サルモネラ（Salmonella）、大腸菌O157、リステリア（Listeria monocytogenes）、カンピロバクター（Campylobacter）です。

目次

第1章 レポート概要

• 業界の現状分析と成長可能性の展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Abbott
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Eiken Chemical Co., Ltd.
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• GlaxoSmithKline
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 世界のサルモネラ菌検査・治療市場：検査法別
  • 培養ベース法
  • 分子ベース法
  • 免疫測定法
• 世界のサルモネラ菌検査・治療市場：サンプルの種類別
  • 食品
  • 水
  • 環境表面
• 世界のサルモネラ菌検査・治療市場：用途別
  • 臨床診断
  • 食品安全検査
  • 動物用診断薬

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 世界のその他の地域

第6章 企業プロファイル

• 3M Co.
• Becton, Dickinson, and Company
• Biomerieux
• Bio-Rad Laboratories, Inc.
• Enzo Life Sciences, Inc.
• Hardy Diagnostics
• IDEXX Laboratories, Inc.
• Merck KGaA
• Mylab Discovery Solutions Pvt. Ltd.
• PerkinElmer Inc.
• Shimadzu Diagnostics Corp.
• Thermo Fisher Scientific Inc.

LIST OF TABLES

• 1. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
• 2. GLOBAL CULTURE-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 3. GLOBAL MOLECULAR-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL IMMUNOASSAYS FOR SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
• 6. GLOBAL SALMONELLA TESTING AND TREATMENT ON FOOD MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 7. GLOBAL SALMONELLA TESTING AND TREATMENT ON WATER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 8. GLOBAL SALMONELLA TESTING AND TREATMENT ON ENVIRONMENTAL SURFACES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 10. GLOBAL SALMONELLA CLINICAL DIAGNOSTICS TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 11. GLOBAL SALMONELLA FOOD SAFTY TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 12. GLOBAL SALMONELLA VETERINARY DIAGNOSTICS TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 13. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 14. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 15. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
• 16. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
• 17. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 18. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 19. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
• 20. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
• 21. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 22. ASIA-PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 23. ASIA- PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
• 24. ASIA- PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
• 25. ASIA- PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 26. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
• 27. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
• 28. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE BY TESTING MODE, 2022 VS 2030 (%)
• 2. GLOBAL CULTURE-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL MOLECULAR-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL MOLECULAR-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE BY SAMPLE TYPE, 2022 VS 2030 ($ MILLION)
• 6. GLOBAL SALMONELLA TESTING AND TREATMENT ON FOOD MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL SALMONELLA TESTING AND TREATMENT ON WATER MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL SALMONELLA TESTING AND TREATMENT ON ENVIRONMENTAL SURFACES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 10. GLOBAL SALMONELLA CLINICAL DIAGNOSTICS TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL SALMONELLA FOOD SAFTY TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 12. GLOBAL SALMONELLA VETERINARY DIAGNOSTICS TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 13. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 14. US SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 15. CANADA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 16. UK SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 17. FRANCE SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 18. GERMANY SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 19. ITALY SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 20. SPAIN SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 21. REST OF EUROPE SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 22. INDIA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 23. CHINA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 24. JAPAN SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 25. SOUTH KOREA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 26. REST OF ASIA-PACIFIC SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
• 27. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Salmonella Testing and Treatment Market Size, Share & Trends Analysis Report by Testing Method (Culture-based Methods, Molecular-based Methods, and Immunoassays), by Sample Type (Food, Water, and Environmental Surfaces), and by Application (Clinical Diagnostics, Food Safety Testing, and Veterinary Diagnostics)Forecast Period (2023-2030).

The global salmonella testing and treatment market is anticipated to grow at a CAGR of 7.5% during the forecast period (2023-2030). Salmonella is a bacterial disease that affects the intestinal tract. Salmonella bacteria typically live in animal and human intestines and are shed through stool (feces). Humans become infected most frequently through polluted water or food. The increasing number of patients suffering from food infection is the primary factor supporting the market growth. According to the Department of Agriculture, Environment and Rural Affairs, over 2,500 strains (serovars) of Salmonella are known most of which rarely cause disease.

Furthermore, certain strains, such as salmonella enteritidis and salmonella typhimurium, may cause human disease. Hence, the increasing awareness among people and government initiatives for the prevention of salmonella infection is another factor driving the salmonella testing and treatment market globally. For instance, in December 2003, Parliament and Council Regulation on the control of salmonella to ensure that proper and effective measures were taken to detect and control Salmonella and other zoonotic agents at all relevant stages of production, processing, and distribution, to reduce their prevalence and the risk they pose to public health.

Segmental Outlook

The global salmonella testing and treatment market is segmented on the testing method, sample type, and application. Based on the testing method, the market is sub-segmented into culture-based Methods, molecular-based Methods, and immunoassays. Based on sample type, the market is sub-segmented into food, water, and environmental surfaces. Further, based on application, the market is sub-segmented into clinical diagnostics, food safety testing, and veterinary diagnostics.

The Molecular-Based Methods Sub-Segment is Anticipated to Hold a Considerable Share of the Global Salmonella Testing and Treatment Market

Among the industry verticals, the molecular-based method sub-segment is expected to hold a considerable share of the global salmonella testing and treatment market. The segmental growth is attributed to the adoption of testing methods such as polymerase chain reaction (PCR), DNA, loop-mediated isothermal amplification (LAMP), Nucleic acid sequence-based amplification (NASBA), recombinase polymerase amplification (RPA) and whole-genome sequencing. For Instance, in March 2012, Abbott collaborated with Genetics Laboratory, Inc. (GenLab) on the development of a molecular diagnostic test that will be designed to rapidly detect microorganisms that cause orthopedic infections. Under the terms of the agreement, Abbott, in conjunction with GenLab, will develop and commercialize the new assay for use on the PLEX-ID™ automated microbial identification system.

Regional Outlook

The global salmonella testing and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, European Union has specific regulations in place for Salmonella testing in various food categories, such as poultry and eggs, and also has a focus on food safety and implements strict regulations for ensuring the quality of food products.

The North America Region is Expected to Grow at a Significant CAGR in the Global Salmonella Testing and Treatment Market

Among all regions, the North America region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to a high prevalence of food-borne illnesses in North America. According to the Centers for Disease Control and Prevention (CDC), the US estimates that Salmonella is responsible for 1.4 million infections, 26,500 hospitalizations, and 420 fatalities. With the creation of the Interagency Food Safety Analytics Collaboration (IFSAC) in 2011; CDC, the U.S. Food and Drug Administration (FDA), and the U.S. Department of Agriculture's Food Safety and Inspection Service (USDA-FSIS) agreed to improve data and methods used to estimate foodborne illness source attribution and provide timely estimates of the food sources of four priority foodborne pathogens: Salmonella, Escherichia coli O157, Listeria monocytogenes and Campylobacter.

Market Players Outlook

The major companies serving the salmonella testing and treatment market include Abbott, Eiken Chemical Co., Ltd., GlaxoSmithKline, 3M, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2017, Merck KGaA acquired Biocontrol to Strengthen its Position in food safety testing the global spotlight on the importance of food safety has grown given the increased incidents of outbreaks and recalls with foodborne diseases often caused by consuming a wide range of foods including undercooked meat, eggs, fresh produce and dairy products contaminated by Salmonella, Listeria, E. coli O157H7 and Campylobacter.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global salmonella testing and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Abbott
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Eiken Chemical Co., Ltd.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. GlaxoSmithKline
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Salmonella Testing and treatment Market by Testing Method
  • 4.1.1. Culture-Based Methods
  • 4.1.2. Molecular-Based Methods
  • 4.1.3. Immunoassays
• 4.2. Global Salmonella Testing and treatment Market by Sample Type
  • 4.2.1. Food
  • 4.2.2. Water
  • 4.2.3. Environmental Surfaces
• 4.3. Global Salmonella Testing and treatment Market by Application
  • 4.3.1. Clinical Diagnostics
  • 4.3.2. Food Safety Testing
  • 4.3.3. Veterinary Diagnostics

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. 3M Co.
• 6.2. Becton, Dickinson, and Company
• 6.3. Biomerieux
• 6.4. Bio-Rad Laboratories, Inc.
• 6.5. Enzo Life Sciences, Inc.
• 6.6. Hardy Diagnostics
• 6.7. IDEXX Laboratories, Inc.
• 6.8. Merck KGaA
• 6.9. Mylab Discovery Solutions Pvt. Ltd.
• 6.10. PerkinElmer Inc.
• 6.11. Shimadzu Diagnostics Corp.
• 6.12. Thermo Fisher Scientific Inc.